Detalhe da pesquisa
1.
Phase 1b study of mirvetuximab soravtansine, a folate receptor alpha (FRα)-targeting antibody-drug conjugate, in combination with carboplatin and bevacizumab in patients with platinum-sensitive ovarian cancer.
Gynecol Oncol;
185: 186-193, 2024 Jun.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38447347
2.
Safety and efficacy of mirvetuximab soravtansine, a folate receptor alpha (FRα)-targeting antibody-drug conjugate (ADC), in combination with bevacizumab in patients with platinum-resistant ovarian cancer.
Gynecol Oncol;
170: 241-247, 2023 03.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36736157
3.
Kinome Profiling of Primary Endometrial Tumors Using Multiplexed Inhibitor Beads and Mass Spectrometry Identifies SRPK1 as Candidate Therapeutic Target.
Mol Cell Proteomics;
19(12): 2068-2090, 2020 12.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32994315
4.
Phase Ib study of mirvetuximab soravtansine, a folate receptor alpha (FRα)-targeting antibody-drug conjugate (ADC), in combination with bevacizumab in patients with platinum-resistant ovarian cancer.
Gynecol Oncol;
157(2): 379-385, 2020 05.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32081463
5.
The role of adjuvant radiation in lymph node positive endometrial adenocarcinoma.
Gynecol Oncol;
141(3): 434-439, 2016 06.
Artigo
em Inglês
| MEDLINE
| ID: mdl-27090796
6.
Perceived importance of weight loss and exercise among endometrial cancer survivors with overweight or obesity: Implications for lifestyle modification interventions.
Obes Sci Pract;
9(6): 661-669, 2023 Dec.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38090692
7.
Non-Gestational Ovarian Choriocarcinoma: A Rare Ovarian Cancer Subtype.
Diagnostics (Basel);
12(3)2022 Feb 22.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35328112
8.
Functional proteomics interrogation of the kinome identifies MRCKA as a therapeutic target in high-grade serous ovarian carcinoma.
Sci Signal;
13(619)2020 02 18.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32071169
9.
Active Estrogen Receptor-alpha Signaling in Ovarian Cancer Models and Clinical Specimens.
Clin Cancer Res;
23(14): 3802-3812, 2017 Jul 15.
Artigo
em Inglês
| MEDLINE
| ID: mdl-28073843
10.
A review of dendritic cell therapy for cancer: progress and challenges.
BioDrugs;
27(5): 453-68, 2013 Oct.
Artigo
em Inglês
| MEDLINE
| ID: mdl-23592406
11.
Vertebral artery dissection and cerebral infarction in a patient with recurrent ovarian cancer receiving bevacizumab.
Gynecol Oncol Case Rep;
5: 37-9, 2013.
Artigo
em Inglês
| MEDLINE
| ID: mdl-24371692
12.
A dendritic cell vaccine pulsed with autologous hypochlorous acid-oxidized ovarian cancer lysate primes effective broad antitumor immunity: from bench to bedside.
Clin Cancer Res;
19(17): 4801-15, 2013 Sep 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-23838316
13.
Immunotherapy in ovarian cancer.
Hum Vaccin Immunother;
8(9): 1179-91, 2012 Sep.
Artigo
em Inglês
| MEDLINE
| ID: mdl-22906947
14.
Targeted treatment of recurrent platinum-resistant ovarian cancer: current and emerging therapies.
Cancer Manag Res;
3: 25-38, 2011.
Artigo
em Inglês
| MEDLINE
| ID: mdl-21734812